GLP-1 Use and Compounding Draw Growing Scrutiny
publishers 3articles 3first reported 22 Sep, 20:45 UTCdeveloping since 24 Sep · 3 editions
More than 1.1 million people are using GLP-1 drugs for reasons not approved by the U.S. Food and Drug Administration, according to NewsNation.
The FDA has also warned a major compounding pharmacy that it violated federal law by producing copies of widely used weight-loss drugs in “inordinate amounts,” CBS News reported.
Separately, debate continues over whether GLP-1 drugs should be used to treat obesity in children, an issue examined by New Scientist.
HOW THIS STORY WAS MADE
Written from 3 articles, 1 with the publisher's own text; 3 independent newsrooms once syndicated copies count as one; the editor revised it.
- Publishers
- 3
- Source articles
- 3
- Given to the writer
- 3, 1 with the article's own text
- Independent newsrooms
- 3
- Second model (editor)
- revised
- Publication gate
- passed
- Human review
- none
Written by a language model from the sources above, then checked by a second model that may only cut, attribute or correct. How it works →